Sudden cardiac death in long-term follow-up in patients treated with primary percutaneous coronary intervention.

Objective. Most studies analyzing predictors of sudden cardiac death (SCD) after acute myocardial infarction included only high-risk patients or index reperfusion had not been performed in all patients. The aim of our study was to analyze the incidence of SCD and determine the predictors of SCD occurrence during 6-year follow-up of unselected patients with ST-elevation myocardial infarction (STEMI), treated with primary percutaneous coronary intervention (pPCI). Method. we analysed 3114 STEMI patients included included in the University Clinical Center of Serbia STEMI Register. Patients presenting with cardiogenic schock were excluded. Echocardiographic examination was performed before hospital discharge. Results. During 6-year follow-up, lethal outcome was registered in 297 (9.5%) patients, of whom 95 (31.9%) had SCD. The highest incidence of SCD was recorded in the first year of follow-up, when SCD was registered in 25 patients, which is 26.3% of the total number of patients who had had SCD, i.e. 0.8% of the patients analyzed. The independent predictors for the occurrence of SCD during 6-year follow-up were EF < 45% (HR 3.07, 95% 1.87-5.02), post-procedural TIMI flow <3 (HR 2.59, 95%CI 1.37-5.14), reduced baseline kidney function (HR 1.87, 95%CI 1.12-2.93) and Killip class >1 at admission (HR 1.69, 95%CI 1.23-2.97). Conclusion. There is a low incidence of SCD in unselected STEMI patients treated with primary PCI. Predictors of SCD occurence during long-term follow-up in analyzed patients are clinical variables that are easily recorded during index hospitalization and include: EF ≤45%, post-procedural flow TIMI < 3, Killip class >1, and reduced baseline kidney function.

[1]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[2]  Yoshio Kobayashi,et al.  Factors that predict ventricular arrhythmias in the late phase after acute myocardial infarction , 2021, ESC heart failure.

[3]  M. Ueda,et al.  Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: A prospective propensity score–matched analysis from the Nippon Storm Study , 2021, Heart rhythm O2.

[4]  M. Pfeffer,et al.  Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database. , 2020, European heart journal. Acute cardiovascular care.

[5]  M. Pfeffer,et al.  Predictors of sudden cardiac death in high‐risk patients following a myocardial infarction , 2020, European journal of heart failure.

[6]  M. Pfeffer,et al.  Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non‐sudden cardiac death in myocardial infarction survivors with heart failure , 2019, European journal of heart failure.

[7]  Z. Siudak,et al.  Radial Approach Expertise and Clinical Outcomes of Percutanous Coronary Interventions Performed Using Femoral Approach , 2019, Journal of clinical medicine.

[8]  I. Kallikazaros,et al.  Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study , 2019, European heart journal.

[9]  D. Atar,et al.  Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction. , 2018, International journal of cardiology.

[10]  J. Chandrasekhar,et al.  Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI , 2016, Open Heart.

[11]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[12]  C. Hassager,et al.  Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – is it necessary? , 2015, European heart journal. Acute cardiovascular care.

[13]  W. Hua,et al.  Incidence and predictors of sudden cardiac death in patients with reduced left ventricular ejection fraction after myocardial infarction in an era of revascularisation , 2014, Heart.

[14]  I. Mrdović,et al.  Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register , 2014, European heart journal. Acute cardiovascular care.

[15]  G. Hindricks,et al.  Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? , 2013, European heart journal.

[16]  E. Vittinghoff,et al.  Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. , 2011, Archives of internal medicine.

[17]  N. Hagiwara,et al.  Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry , 2008, Heart.

[18]  Robert S Sheldon,et al.  Noninvasive risk assessment early after a myocardial infarction the REFINE study. , 2007, Journal of the American College of Cardiology.

[19]  J. Ottervanger,et al.  Mortality in patients with left ventricular ejection fraction , 2007, The American journal of cardiology.

[20]  V. Fuster,et al.  Primary prophylaxis with the implantable cardioverter-defibrillator: The need for improved risk stratification , 2005 .